Geographic disparities in chronic obstructive pulmonary disease (COPD) hospitalization among Medicare beneficiaries in the United States

被引:51
|
作者
Holt, James B. [1 ]
Zhang, Xingyou [1 ]
Presley-Cantrell, Letitia [1 ]
Croft, Janet B. [1 ]
机构
[1] US Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA
关键词
COPD prevention; environmental risk factors; public health; population; CHRONIC-BRONCHITIS; NATIONAL-HEALTH; AIR-POLLUTION; PREVALENCE; EPIDEMIOLOGY; ASSOCIATION; POPULATION; OCCUPATION; MORTALITY; INDUSTRY;
D O I
10.2147/COPD.S19945
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Hospitalizations for persons with chronic obstructive pulmonary disease (COPD) result in significant health care resource use and excess expenditures. Despite well-documented sociodemographic disparities in COPD outcomes, no study has characterized geographic variations in COPD hospitalization across the US. Methods: Almost 3.8 million COPD hospitalization records were extracted from Medicare claims for 1995-2006, and the total population of eligible Medicare beneficiaries was extracted from the Medicare enrollment records to calculate COPD hospitalization rates by Health Service Area (HSA), (n = 949). Spatial cluster analysis and Bayesian hierarchical spatial modeling were used to characterize the geography of COPD hospitalizations. Results: The overall COPD hospitalization rate was 11.30 per 1,000 beneficiaries for the aggregated period 1995-2006. HSA-level COPD hospitalization rates had a median of 11.7 and a range of 3.0 (Cache, UT) to 76.3 (Pike, KY). Excessive hospitalization risk was concentrated in Appalachia, the southern Great Lakes, the Mississippi Delta, the Deep South, and west Texas. In the Bayesian spatial mixture model, 73% of variability of COPD hospitalization relative risk was attributed to unidentified regional social and physical environments shared by HSAs rather than to unique local HSA factors (27%). Conclusion: We discovered distinct geographic patterns in COPD hospitalization rates and risks attributed to both regionally-shared environmental risk factors and HSA-unique environmental contexts. The correlates of these geographic patterns remain to be determined. Geographic comparisons of COPD hospitalization risk provide insights for better public health practice, policies, and programs for COPD prevention.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 50 条
  • [41] Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Arformoterol Following a Respiratory Event
    Navaie, M.
    Ganapathy, V.
    Gilmer, T. P.
    Xu, Z.
    Cho-Reyes, S.
    Celli, B. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [42] Chronic Obstructive Pulmonary Disease Prevalence Among Nonsmokers by Occupation in the United States
    Bang, Ki Moon
    Syamlal, Girija
    Mazurek, Jacek M.
    Wassell, James T.
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2013, 55 (09) : 1021 - 1026
  • [43] Hospitalization for influenza among patients with chronic obstructive pulmonary disease
    Bolge, Susan
    Kariburyo, Furaha
    Yuce, Huseyin
    Fleischhackl, Roman
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [44] The economic burden of chronic obstructive pulmonary disease (COPD) in a US Medicare population
    Menzin, Joseph
    Boulanger, Luke
    Marton, Jeno
    Guadagno, Lisa
    Dastani, Homa
    Dirani, Riad
    Phillips, Amy
    Shah, Hemal
    RESPIRATORY MEDICINE, 2008, 102 (09) : 1248 - 1256
  • [45] Wood Smoke-Associated Chronic Obstructive Pulmonary Disease (COPD) - Underappreciated in the United States?.
    Sood, A.
    Petersen, H.
    Blanchette, C.
    Meek, P.
    Belinsky, S.
    Picchi, M.
    Tesfaigzi, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [46] Mapping the Overlap of Poverty Level and Prevalence of Diagnosed Chronic Kidney Disease Among Medicare Beneficiaries in the United States
    Han, Yun
    Xu, Fang
    Morgenstern, Hal
    Bragg-Gresham, Jennifer
    Gillespie, Brenda W.
    Steffick, Diane
    Herman, William H.
    Pavkov, Meda E.
    Veinot, Tiffany
    Saran, Rajiv
    PREVENTING CHRONIC DISEASE, 2024, 21
  • [47] The Impact of Diabetes Mellitus in Patients with Chronic Obstructive Pulmonary Disease (COPD) Hospitalization
    Gunasekaran, Kulothungan
    Murthi, Swetha
    Elango, Kalaimani
    Rahi, Mandeep Singh
    Thilagar, Bright
    Ramalingam, Sathishkumar
    Voruganti, Dinesh
    Paramasivam, Vijaya Kumar
    Kolandaivel, Krishna Prasad
    Arora, Ashish
    Chandran, Arul
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (02) : 1 - 12
  • [48] Effect of hospitalization on exercise capacity in patients with chronic obstructive pulmonary disease (COPD)
    Antonia Ramon, Maria
    Gimeo-Santos, Elena
    Ferrer, Jaume
    Garcia-Aymerich, Judith
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [49] Inhaled anticholinergic use and all-cause mortality among elderly Medicare beneficiaries with chronic obstructive pulmonary disease
    Ajmera, Mayank
    Shen, Chan
    Pan, Xiaoyun
    Findley, Patricia A.
    Rust, George
    Sambamoorthi, Usha
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 8 : 287 - 294
  • [50] Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment
    Celli, Bartolome R.
    Navaie, Maryam
    Xu, Zhun
    Cho-Reyes, Soojin
    Dembek, Carole
    Gilmer, Todd P.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 1019 - 1031